JPH08511510A - 毛胞に有益な配合物を送達する方法 - Google Patents
毛胞に有益な配合物を送達する方法Info
- Publication number
- JPH08511510A JPH08511510A JP6522428A JP52242894A JPH08511510A JP H08511510 A JPH08511510 A JP H08511510A JP 6522428 A JP6522428 A JP 6522428A JP 52242894 A JP52242894 A JP 52242894A JP H08511510 A JPH08511510 A JP H08511510A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- liposome composition
- liposome
- nucleic acid
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y110/00—Oxidoreductases acting on diphenols and related substances as donors (1.10)
- C12Y110/03—Oxidoreductases acting on diphenols and related substances as donors (1.10) with an oxygen as acceptor (1.10.3)
- C12Y110/03001—Catechol oxidase (1.10.3.1), i.e. tyrosinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/10—Preparations for permanently dyeing the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
- C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
- C12N9/0059—Catechol oxidase (1.10.3.1), i.e. tyrosinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/18—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with another compound as one donor, and incorporation of one atom of oxygen (1.14.18)
- C12Y114/18001—Tyrosinase (1.14.18.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.有益な化合物の有効量を含むリポソームで、該リポソームは有益な該化 合物を選択的に毛胞へ送達でき、かつ、有益な該化合物が該毛胞の外側にある細 胞に好ましくない効果を与える嫌油性の分子あるいは親油性の分子である、リポ ソームを含むリポソーム組成物。 2.該有益な化合物がメラニンおよびその変異体を含む、請求の範囲1のリ ポソーム組成物。 3.該有益な化合物が毛髪染色を含む、請求の範囲1のリポソーム組成物。 4.該有益な化合物がチロシナーゼを含む、請求の範囲1のリポソーム組成 物。 5.該有益な化合物がヒト・チロシナーゼを発現できる核酸を含む、請求の 範囲1のリポソーム組成物。 6.特許請求の範囲5のリポソーム組成物で、当該核酸が、SEQ ID NO 1で 示されたチロシナーゼ蛋白質配列のアミノ酸残基配列特性を含めたヒト・チロシ ナーゼを暗号化するもの。 7.特許請求の範囲5のリポソーム組成物で、当該核酸がヒトp-糖蛋白質を 発現できるもの。 8.特許請求の範囲7のリポソーム組成物で、当該核酸がヒトMDR-1遺伝子 を定義し、SEQ ID NO 2で示されたp-糖蛋白質配列のアミノ酸残基配列特性を もつp-糖蛋白質を発現できるもの。 9.特許請求の範囲5のリポソーム組成物で、当該リポソーム組成が、0.2 〜1.2マイクロモルのリン脂質につき、約100マイクログラムの当該核酸を含有す るもの。 10.特許請求の範囲1のリポソーム組成物で、当該リポソーム組成がpHに対 して感応するリポソームを含むもの。 11.特許請求の範囲10のリポソーム組成物で、pHに感応する当該リポソーム がPEおよびOEをモル比率7:3で含むもの。 12.特許請求の範囲1のリポソーム組成物で、当該リポソーム組成がPC,EPC , DOPC,DPPC,PE,DOPEおよびコレステロールから成るグループから選ばれた第一リ ン脂質を含むもの。 13.特許請求の範囲12のリポソーム組成物で、当該リポソーム組成のPC:PE :コレステロールの比率が5:2:3であるもの。 14.特許請求の範囲12のリポソーム組成物で、当該リポソーム組成がさらに D282,D378,D383.D3886,D3897およびD3899から成るグループから選ばれた陽イオ ン・リン脂質を含むもの。 15.特許請求の範囲14のリポソーム組成物で、当該リポソーム組成が、当該 第一リン脂質および当該陽イオン・リン脂質を0.8:1.0-1.2のモル比率で含むも の。 16.哺乳動物の毛髪の色を修復する方法で、当該方法が、治療学的に有効な 量のリポソーム組成物を多数の毛胞をもつ当該哺乳動物の皮膚部位に塗布するこ と、当該リポソームの組成が少なくとも1種類の選択された毛髪色修復薬剤の有 効量を含むリポソームを含むこと、ならびに、当該リポソームが毛髪色修復薬剤 を当該毛胞へ選択的に送達できることを特徴とする方法。 17.特許請求の範囲16の方法で、長期にわたる毛髪色の修復のため、当該塗 布が一定の間隔で繰り返し行われる方法。 18.特許請求の範囲16の方法で、当該毛髪色修復薬剤がメラニンおよびその 変異体を含む方法。 19.特許請求の範囲16の方法で、当該毛髪色修復薬剤が毛髪染料で構成され る方法 20.特許請求の範囲16の方法で、当該毛髪色修復薬剤がチロシナーゼで構成 される方法。 21.特許請求の範囲16の方法で、当該毛髪色修復薬剤が当該毛胞の細胞内で ヒト・チロシナーゼを発現できる核酸を含む方法。 22.特許請求の範囲21の方法で、当該核酸がSEQ ID NO 1で示されたチロシ ナーゼ蛋白質配列の特性をもつアミノ酸残基配列を含めたヒト・チロシナーゼを 暗号化する方法。 23.特許請求の範囲21の方法で、当該リポソーム組成物がリン脂質0.2〜1.2 マ イクロモルにつき当該核酸100グラムを含有する方法。 24.特許請求の範囲16の方法で、当該リポソーム組成物がpHに感応するリポ ソームを含む方法。 25.特許請求の範囲24の方法で、pHに感応する当該リポソームが、PEおよび OEを7:3の比率で含有する方法 26.特許請求の範囲16の方法で、当該リポソーム組成物、PC,EPC,DOPC,DPPC ,PE,DOPEおよびコレステロールから成るグループから選ばれた第一リン脂質を含 む方法。 27.特許請求の範囲26の方法で、当該リポソーム組成物がPC:PE:コレステロ ールを5:2:3の比率で含む方法。 28.特許請求の範囲26の方法で、当該リポソーム組成物がさらに、D282,D37 8,D383,D3886,D3897およびD3899からなるグループから選ばれた陽イオン・リン 脂質を含む方法。 29.特許請求の範囲28の方法で、当該リポソーム組成物が当該第一リン脂質 および当該陽イオン・リン脂質を0.8:1.0-1.2のモル比率で含む方法。 30.有益な配合物を哺乳動物の毛胞へ直接的かつ選択的に送達する方法で、 当該方法が多数の毛胞をもつ哺乳動物の皮膚部位にリポソーム組成物を局所的に 塗布するステップから構成され、当該リポソーム組成物が少なくとも1種類の効 果的で有効量の選択化合物を含有するリポソームを含み、当該リポソームが当該 有効成分を当該毛胞へ選択的に送達でき、かつ、当該有効成分が当該毛胞の外部 細胞に好ましくない効果を与える嫌油性分子または親油性分子であるため、当該 有効成分が当該毛胞へ優先的に伝達され当該毛胞へ浸透する方法。 31.特許請求の範囲30の方法で、当該化合物がメラニンおよびその変異体を 含む方法。 32.特許請求の範囲30の方法で、当該化合物が毛髪染料を含む方法。 33.特許請求の範囲30の方法で、当該化合物が蛋白質を含む方法。 34.特許請求の範囲33の方法で、当該蛋白質がチロシナーゼである方法。 35.特許請求の範囲33の方法で、当該蛋白質がp-糖蛋白質である方法。 36.特許請求の範囲33の方法で、当該蛋白質がヒト腫瘍成長因子アルファで ある方法。 37.特許請求の範囲30の方法で、当該化合物が核酸を含む方法。 38.特許請求の範囲37の方法で、当該核酸が有効量の置換療法蛋白質を発現 できる方法。 39.特許請求の範囲38の方法で、当該発現蛋白質がチロシナーゼである方法 40.特許請求の範囲39の方法で、当該蛋白質がSEQ ID NO 1で示された配列 のアミノ酸残基配列特性を有する方法。 41.特許請求の範囲38の方法で、当該発現蛋白質がヒト遺伝子MDR-1により 発現されるp-糖蛋白質である方法。 42.特許請求の範囲41の方法で、当該蛋白質がSEQ ID NO 2で示された配列 のアミノ酸残基配列特性を有する方法。 43.特許請求の範囲37の方法で、当該リポソーム組成が0.2〜1.2マイクロモ ルのリン酸につき約100マイクログラムの当該核酸を含有する方法。 44.特許請求の範囲37の方法で、当該核酸が毛髪成長刺激遺伝子を含む方法 。 45.特許請求の範囲30の方法で、毛胞を含んだ当該皮膚が哺乳動物の表面に あり、当該送達が生体内で起る方法。 46.特許請求の範囲45の方法で、当該哺乳動物がヒトである方法。 47.特許請求の範囲30の方法で、当該リポソーム組成物がpH感応性ルポソー ムを含む方法。 48.特許請求の範囲47の方法で、pHに感応する当該リポソームがPEおよびOE を7:3のモル比率で含有する方法。 49.特許請求の範囲30の方法で、当該リポソーム組成物がPC,EPC,DOPC,DPPC ,PE,DOPEおよびコレステロールから成るグループから選ばれた第一リン脂質を含 む方法。 50.特許請求の範囲49の方法で、当該リポソーム組成物がPC:PE:コレステロ ールを5:2:3の比率で含む方法。 51.特許請求の範囲49の方法で、当該リポソーム組成物がさらにD282,D378, D383,D3886,D3897およびD3899から成るグループから選択された陽イオン・リン 脂質を含む方法 52.特許請求の範囲51の方法で、当該リポソーム組成物が当該第一リン脂質 および当該陽イオン・リン脂質を0.8:1.0-1.2のモル比率で含む方法。 53.特許請求の範囲30の方法で、当該核酸がアンチセンス分子を暗号化する 方法。 54.哺乳動物において化学療法に起因する脱毛症を抑制する方法で、有効量 のリポソーム組成物を当該哺乳動物の多数の毛胞をもつ皮膚部位に治療法的に塗 布すること、当該リポソーム組成物が当該毛胞の細胞内で当該毛胞に化学的抵抗 をを与える蛋白質を発現できる有効量の核酸を含有するリポソームを含むこと、 ならびに、当該リポソームが当該核酸を当該毛胞に選択的に送達できること、を 特徴とする方法 55.特許請求の範囲54の方法で、長期にわたる化学抵抗を与えるため当該塗 布が一定の間隔で繰り返し行われる方法。 56.特許請求の範囲54の方法で、当該核酸が当該毛胞の細胞内でヒトp-糖蛋 白質を発現できる方法。 57.特許請求の範囲54の方法で、当該核酸がヒトMDR-1遺伝子を定義し、SEQ ID NO 2で示されたp-糖蛋白質配列のアミノ酸残基配列特性をもつp-糖蛋白質を 発現できる方法。 58.特許請求の範囲54の方法で、当該リポソームの組成物がリン酸0.2〜1.2 マイクロモルあたり約100マイクログラムの当該核酸を含有する方法。 59.特許請求の範囲54の方法で、当該リポソーム組成物がpHに感応するリポ ソームを含む方方法。 60.特許請求の範囲59の方法で、pHに感応する当該リポソームがPEおよびOE を7:3のモル比率で含む方法。 61.特許請求の範囲54の方法で、当該リポソーム組成物がPC,EPC,DOPC,DPPC ,PE,DOPEおよびコレステロールから成るグループから選択された第一リン酸を含 む方法。 62.特許請求の範囲61の方法で、当該リポソーム組成物がPC:PE:コレステ ロールを5:2:3の比率で含むもの。 63.特許請求の範囲61の方法で、当該リポソーム組成物がさらにD282,D378, D383,D3886,D3897およびD3899から成るグループから選択された陽イオン・リン 脂質を含む方法。 64.特許請求の範囲61の方法で、当該リポソーム組成物が当該第一リン脂質 および当該陽イオン・リン脂質を0.8:1.0-1.2の比率で含有する方法。
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US041,553 | 1987-04-22 | ||
US4155393A | 1993-04-02 | 1993-04-02 | |
US08/041,553 | 1993-04-02 | ||
US08/181,471 | 1994-01-13 | ||
US181,471 | 1994-01-13 | ||
US08/181,471 US5641508A (en) | 1994-01-13 | 1994-01-13 | Method for delivering melanin to hair follicles |
PCT/US1994/003634 WO1994022468A1 (en) | 1993-04-02 | 1994-04-01 | Method for delivering beneficial compositions to hair follicles |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08511510A true JPH08511510A (ja) | 1996-12-03 |
JP2950520B2 JP2950520B2 (ja) | 1999-09-20 |
Family
ID=26718278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6522428A Expired - Lifetime JP2950520B2 (ja) | 1993-04-02 | 1994-04-01 | 毛胞に有益な配合物を送達する方法 |
Country Status (8)
Country | Link |
---|---|
US (5) | US5753263A (ja) |
EP (1) | EP0692972B2 (ja) |
JP (1) | JP2950520B2 (ja) |
AT (1) | ATE209887T1 (ja) |
AU (1) | AU6554594A (ja) |
CA (1) | CA2159626C (ja) |
DE (1) | DE69429337T3 (ja) |
WO (1) | WO1994022468A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008053983A1 (fr) * | 2006-11-02 | 2008-05-08 | Hokkaido University | Composition d'ionophorèse pour une administration par les pores des cheveux |
JP2009507876A (ja) * | 2005-09-15 | 2009-02-26 | ノヴォソム アクチェンゲゼルシャフト | 両性リポソームにおけるまたはそれに関する改善 |
JP2012157365A (ja) * | 1999-12-10 | 2012-08-23 | Anticancer Inc | 移植用皮膚組織材料 |
Families Citing this family (115)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2159626C (en) | 1993-04-02 | 2001-10-02 | Lingna Li | Method for delivering beneficial compositions to hair follicles |
US7556825B2 (en) * | 1993-04-02 | 2009-07-07 | Anticancer, Inc. | Method for promoting hair growth |
US20030026782A1 (en) * | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US5480901A (en) * | 1994-10-07 | 1996-01-02 | Zynaxis, Inc. | Method for reducing unwanted cellular adhesions |
US5756122A (en) * | 1995-06-07 | 1998-05-26 | Georgetown University | Liposomally encapsulated nucleic acids having high entrapment efficiencies, method of manufacturer and use thereof for transfection of targeted cells |
US6844326B2 (en) * | 1995-06-07 | 2005-01-18 | Anticancer, Inc. | Treatment of alopecia |
US6261597B1 (en) * | 1995-08-31 | 2001-07-17 | Seymour J. Kurtz | Method for treating periodontal disease |
US6459805B1 (en) * | 1996-03-26 | 2002-10-01 | Childrens Hospital Los Angeles | Fluorescence digital imaging microscopy system |
US5766214A (en) * | 1996-04-18 | 1998-06-16 | Mehl, Sr.; Thomas L. | Melanin enhanced photothermolysis hair removal |
JP2000511541A (ja) * | 1996-05-30 | 2000-09-05 | ユニバーシティー オブ ブリティッシュ コロンビア | リポソームアンチセンス送達の効果の増強 |
US20030045492A1 (en) * | 1997-08-13 | 2003-03-06 | Tang De-Chu C. | Vaccination by topical application of recombinant vectors |
US6348450B1 (en) * | 1997-08-13 | 2002-02-19 | The Uab Research Foundation | Noninvasive genetic immunization, expression products therefrom and uses thereof |
US20030125278A1 (en) * | 1997-08-13 | 2003-07-03 | Tang De-Chu C. | Immunization of animals by topical applications of a salmonella-based vector |
US6706693B1 (en) | 1997-08-13 | 2004-03-16 | The Uab Research Foundation | Vaccination by topical application of genetic vectors |
US6716823B1 (en) | 1997-08-13 | 2004-04-06 | The Uab Research Foundation | Noninvasive genetic immunization, expression products therefrom, and uses thereof |
AU758368B2 (en) * | 1998-01-05 | 2003-03-20 | University Of Massachusetts | Enhanced transport using membrane disruptive agents |
US6348348B1 (en) * | 1998-04-07 | 2002-02-19 | The Carnegie Institution Of Washington | Human hairless gene and protein |
CA2329252A1 (en) * | 1998-05-21 | 1999-11-25 | Isis Pharmaceuticals Inc. | Compositions and methods for topical delivery of oligonucleotides |
US20030022854A1 (en) * | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
US6693086B1 (en) * | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
US20040247662A1 (en) * | 1998-06-25 | 2004-12-09 | Dow Steven W. | Systemic immune activation method using nucleic acid-lipid complexes |
ATE312916T1 (de) * | 1998-10-27 | 2005-12-15 | Anticancer Inc | Herstellung eines retrovirus, welches den mel- lokus von streptomyces enthält, sowie dessen expression in säugetierzellen |
US6372489B1 (en) | 1998-10-27 | 2002-04-16 | Anticancer, Inc. | Method and model for hair pigmentation |
FR2791671B1 (fr) | 1999-04-01 | 2001-05-11 | Oreal | Nouveaux composes derives d'esters d'acide benzoique, composition les comprenant et utilisation |
US20040009936A1 (en) * | 1999-05-03 | 2004-01-15 | Tang De-Chu C. | Vaccine and drug delivery by topical application of vectors and vector extracts |
GB9918670D0 (en) * | 1999-08-06 | 1999-10-13 | Celltech Therapeutics Ltd | Biological product |
CA2380640A1 (en) * | 1999-08-18 | 2001-02-22 | Kyowa Hakko Kogyo Co., Ltd. | Hair-growing agent |
DE60040264D1 (de) * | 1999-10-29 | 2008-10-30 | Shiseido Co Ltd | Verfahren zur Messung von Hautabsorption |
AU2764801A (en) * | 2000-01-07 | 2001-07-24 | University Of Washington | Enhanced transport of agents using membrane disruptive agents |
WO2001051010A1 (en) * | 2000-01-11 | 2001-07-19 | Clinical Results, Inc. | Dermatological suspensions (micro-matrix) |
JP2004515453A (ja) * | 2000-05-05 | 2004-05-27 | ウィスコンシン・アルムナイ・リサーチ・ファウンデーション | 癌を化学療法および放射線療法に付する間に細胞を保護するための組成物および方法 |
AU2001268594A1 (en) * | 2000-06-22 | 2002-01-02 | Michael F. Holick | Regulation of cellproliferation and differentiation using topically applied peptides |
US20040022838A1 (en) * | 2001-06-20 | 2004-02-05 | Holick Michael F. | Regulation of cell proliferation and differentiation using topically applied peptides |
WO2002007674A2 (en) * | 2000-07-21 | 2002-01-31 | Ceramoptec Industries, Inc. | Enhancing compound penetration into hair follicles |
EP1349565A2 (en) * | 2000-10-06 | 2003-10-08 | HOLICK, Michael F | Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
DE10109897A1 (de) * | 2001-02-21 | 2002-11-07 | Novosom Ag | Fakultativ kationische Liposomen und Verwendung dieser |
US6984395B2 (en) * | 2001-04-11 | 2006-01-10 | Qlt, Inc. | Drug delivery system for hydrophobic drugs |
EP1381349A4 (en) * | 2001-04-27 | 2004-09-29 | Gen Hospital Corp | TYROSINASEBESTIMMUNG |
US7923431B2 (en) * | 2001-12-21 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
US7858117B2 (en) * | 2002-02-21 | 2010-12-28 | Novosom Ag | Amphoteric liposomes and their use |
AU2003233464A1 (en) * | 2002-03-29 | 2003-10-13 | Bristol-Myers Squibb Corporation | Lipid mediated screening of drug candidates for identification of active compounds |
EP1352631A1 (en) * | 2002-04-08 | 2003-10-15 | Kao Corporation | Hair dye composition |
FR2840531B1 (fr) * | 2002-06-11 | 2004-10-29 | Oreal | Composition cosmetique comprenant un agent mimetique de l'activite de la dopachrome tautomerase (trp-2) pour lutter contre la canitie |
CA2487945A1 (fr) * | 2002-06-11 | 2003-12-18 | L'oreal | Utilisation d'un agent mimetique de l'activite de la dopachrome tautomerase (trp-2) comme agent protecteur des melanocytes du follicule pileux et applications |
FR2840530B1 (fr) * | 2002-06-11 | 2004-12-24 | Oreal | Composition cosmetique comprenant un agent inducteur de l'expression de la dopachrome tautomerase (trp-2) pour lutter contre la canitie |
US7585514B2 (en) * | 2002-06-11 | 2009-09-08 | L'oreal | Administration of agents mimicking DOPAchrome tautomerase (TRP-2) activity for protecting hair follicle melanocytes |
WO2004026249A2 (en) * | 2002-09-20 | 2004-04-01 | The General Hospital Corporation | Methods and compositions for preventing skin damage |
US7955288B2 (en) * | 2002-12-11 | 2011-06-07 | Ferrosan Medical Devices A/S | Gelatine-based materials as swabs |
FR2850864B1 (fr) * | 2003-02-12 | 2007-04-13 | Oreal | Utilisation d'un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres |
EP1594438B1 (fr) * | 2003-02-12 | 2013-07-17 | L'Oréal | Utilisation d'un inhibiteur de 15-hydroxy prostaglandine déshydrogénase pour favoriser la pigmentation de la peau ou des phanères |
US7326717B2 (en) | 2003-05-06 | 2008-02-05 | L'oreal | Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof |
US7244739B2 (en) * | 2003-05-14 | 2007-07-17 | Torreypines Therapeutics, Inc. | Compounds and uses thereof in modulating amyloid beta |
DE10340373A1 (de) * | 2003-08-30 | 2005-03-24 | Henkel Kgaa | Verfahren zur Bestimmung von Haarzyklus-Marken |
US20050058614A1 (en) * | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides |
CA2540725A1 (en) * | 2003-11-05 | 2005-05-26 | Osteoscreen, Inc. | Stimulation of hair growth by ginkgo biloba flavonoids |
US8535711B2 (en) * | 2004-01-23 | 2013-09-17 | Teikoku Pharma Usa, Inc. | Medication disposal system |
US7867511B2 (en) | 2004-01-23 | 2011-01-11 | Travanti Pharma Inc. | Abuse potential reduction in abusable substance dosage form |
WO2005072700A2 (en) * | 2004-01-30 | 2005-08-11 | Ferrosan A/S | Haemostatic sprays and compositions |
US20050181035A1 (en) * | 2004-02-17 | 2005-08-18 | Dow Steven W. | Systemic immune activation method using non CpG nucleic acids |
CA2557532A1 (en) | 2004-04-23 | 2005-11-10 | Angela M. Christiano | Inhibition of hairless protein mrna |
US8168600B2 (en) * | 2004-04-23 | 2012-05-01 | Isis Pharmaceuticals, Inc. | Compositions and methods for topical delivery of oligonucleotides |
US7706873B2 (en) | 2004-05-05 | 2010-04-27 | Mario Ammirati | System and method for controlled delivery of a therapeutic agent to a target location within an internal body tissue |
DE102004028465A1 (de) * | 2004-06-11 | 2005-12-29 | Henkel Kgaa | Färbemittel für keratinhaltige Fasern |
CA2571981C (en) * | 2004-07-09 | 2014-12-30 | Ferrosan A/S | Haemostatic composition comprising hyaluronic acid |
US20060073117A1 (en) * | 2004-10-01 | 2006-04-06 | Stowers Institute For Medical Research | Methods and compositions for controlling hair follicle stem cell fate |
US7964571B2 (en) | 2004-12-09 | 2011-06-21 | Egen, Inc. | Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases |
US7524510B2 (en) * | 2005-02-23 | 2009-04-28 | The Uab Research Foundation | Alkyl-glycoside enhanced vaccination |
US20080193386A1 (en) * | 2005-03-24 | 2008-08-14 | Medigenes Co., Ltd | Compositions for Treating Alopecia or Promoting Hair Growth |
WO2006128084A2 (en) * | 2005-05-27 | 2006-11-30 | The Trustees Of Columbia University In The City Of New York | Trps1-mediated modulation of hair growth |
WO2007109584A1 (en) * | 2006-03-16 | 2007-09-27 | University Of Washington | Temperature-and ph-responsive polymer compositions |
DE102006060154A1 (de) * | 2006-12-18 | 2008-06-19 | Henkel Kgaa | Verfahren zur molekularen Charakterisierung von ergrautem und pigmentiertem Haar |
US7981688B2 (en) | 2007-03-08 | 2011-07-19 | University Of Washington | Stimuli-responsive magnetic nanoparticles and related methods |
US8450273B2 (en) | 2007-04-09 | 2013-05-28 | The Board Of Trustees Of The University Of Arkansas | Fusion proteins of collagen-binding domain and parathyroid hormone |
FR2918885B1 (fr) | 2007-07-17 | 2009-08-28 | Oreal | Utilisation d'extrait de bacterie cultivee sur eau thermale pour diminuer les poches et/ou les cernes perioculaires |
US9144546B2 (en) | 2007-08-06 | 2015-09-29 | Clsn Laboratories, Inc. | Nucleic acid-lipopolymer compositions |
FR2920309B1 (fr) | 2007-08-28 | 2010-05-28 | Galderma Res & Dev | Utilisation de travoprost pour traiter la chute des cheveux |
UA100253C2 (uk) | 2007-11-26 | 2012-12-10 | Сантаріс Фарма А/С | Lna-антагоністи андрогенного рецептора |
US8642831B2 (en) | 2008-02-29 | 2014-02-04 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
FR2928544A1 (fr) * | 2008-03-17 | 2009-09-18 | Oreal | Utilisation d'inhibiteurs de la dopamine-beta hydroxylase pour la pigmentation capillaire. |
FR2928543B1 (fr) * | 2008-03-17 | 2013-08-02 | Oreal | Utilisation d'inhibiteurs de la xanthine oxydase pour la pigmentation capillaire |
FR2928546B1 (fr) * | 2008-03-17 | 2013-08-02 | Oreal | Utilisation d'inhibiteurs de la dopa decarboxylase pour la pigmentation capillaire. |
FR2928545B1 (fr) * | 2008-03-17 | 2013-08-02 | Oreal | Utilisation d'inhibiteurs de monoamines oxydases pour la pigmentation capillaire |
FR2929118B1 (fr) | 2008-03-28 | 2010-05-07 | Oreal | Utilisation de l'association de madecassoside et/ou de terminoloside et d'une arginine pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute |
FR2929117B1 (fr) | 2008-03-28 | 2010-05-07 | Oreal | Utilisation de l'association du 2,4-diaminopyrimidine 3-n-oxyde et du madecassosside et/ou du terminoloside pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute |
US8426214B2 (en) * | 2009-06-12 | 2013-04-23 | University Of Washington | System and method for magnetically concentrating and detecting biomarkers |
US20110117668A1 (en) * | 2009-11-09 | 2011-05-19 | University Of Washington Through Its Center For Commercialization | Self-powered smart diagnostic devices |
US9080933B2 (en) | 2009-11-09 | 2015-07-14 | University Of Washington Through Its Center For Commercialization | Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates |
AU2011326034B2 (en) | 2010-11-12 | 2016-02-04 | Roche Innovation Center Copenhagen A/S | Compositions and methods for treating androgen receptor dependent disorders including cancers |
CN103687590A (zh) | 2011-04-28 | 2014-03-26 | Stc·Unm公司 | 用于靶向给药的多孔纳米颗粒支撑脂双层(原始细胞)及其使用方法 |
CA2842306A1 (en) * | 2011-07-19 | 2013-01-24 | Stc.Unm | Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers |
KR20140068058A (ko) | 2011-09-30 | 2014-06-05 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 경피 패치 처리 시스템 |
KR20140067042A (ko) | 2011-09-30 | 2014-06-03 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 일반 약물 처리 시스템 |
DK2790717T3 (da) | 2011-12-14 | 2018-07-30 | Univ Arkansas | Afgivelse af terapeutiske midler ved hjælp af et kollagenbindende protein |
WO2013120060A1 (en) | 2012-02-09 | 2013-08-15 | The Board Of Trustees Of The University Of Arkansas | Delivery of therapeutic agents by a collagen binding protein |
CN104244928B (zh) | 2012-01-18 | 2016-08-31 | 株式会社百奥尼 | 磁性纳米颗粒-SAMiRNA复合物及其制备方法 |
US11109849B2 (en) | 2012-03-06 | 2021-09-07 | Ferrosan Medical Devices A/S | Pressurized container containing haemostatic paste |
CN104349797B (zh) | 2012-06-12 | 2017-10-27 | 弗罗桑医疗设备公司 | 干止血组合物 |
US20150209245A1 (en) * | 2012-07-10 | 2015-07-30 | Koninklijkie Philips N.V. | Release of molecules from container by selective heating of hair |
CN104662149B (zh) * | 2012-07-26 | 2018-11-20 | 荷兰联合利华有限公司 | 制备重组人酪氨酸酶的方法 |
ES2798899T3 (es) | 2013-02-25 | 2020-12-14 | Novartis Ag | Mutación novedosa del receptor de andrógenos |
JP6390873B2 (ja) | 2013-06-21 | 2018-09-19 | フェッローサン メディカル ディバイス エー/エス | 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ |
CA2917318A1 (en) | 2013-07-05 | 2015-01-08 | Bioneer Corporation | Dengue virus related genes-specific sirna, double-stranded oligo rna molecules comprising the sirna, and composition for the inhibition of dengue virus replication comprising the same |
RU2670164C2 (ru) | 2013-07-05 | 2018-10-18 | Байонир Корпорейшн | Улучшенная олигонуклеотидная конструкция типа наночастицы, обладающая высокой эффективностью, и способ ее получения |
KR20150006742A (ko) * | 2013-07-09 | 2015-01-19 | (주)바이오니아 | 간암 연관 유전자 특이적 siRNA, 그러한 siRNA를 포함하는 이중나선 올리고 RNA 구조체 및 이를 포함하는 암 예방 또는 치료용 조성물 |
AU2014361291B2 (en) | 2013-12-11 | 2017-11-30 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
CN106459974A (zh) | 2014-04-04 | 2017-02-22 | 柏业公司 | 新颖的双链寡rna和包含它的用于预防或治疗纤维化或呼吸系统疾病的药物组合物 |
EP3206726B1 (en) | 2014-10-13 | 2020-05-27 | Ferrosan Medical Devices A/S | Dry composition for use in haemostasis and wound healing |
BR112017013565B1 (pt) | 2014-12-24 | 2021-12-28 | Ferrosan Medical Devices A/S | Seringa para retenção e mistura de primeira e segunda substâncias |
BR112017027695A2 (pt) | 2015-07-03 | 2018-09-04 | Ferrosan Medical Devices As | seringa para retenção e mistura de primeira e segunda substâncias |
WO2018148573A1 (en) | 2017-02-10 | 2018-08-16 | The Board Of Trustees Of The University Of Arkansas | Collagen-binding agent compositions and methods of using the same |
US11389844B2 (en) | 2018-03-20 | 2022-07-19 | Verde Environmental Technologies, Inc. | Blister pack disposal system |
WO2019215274A1 (en) | 2018-05-09 | 2019-11-14 | Ferrosan Medical Devices A/S | Method for preparing a haemostatic composition |
CN112245571A (zh) * | 2020-09-16 | 2021-01-22 | 陕西中鸿科瑞再生医学研究院有限公司 | 一种用于乌发的脂质体制剂及其制备方法 |
US20230000746A1 (en) * | 2021-06-30 | 2023-01-05 | Abe Pharmaceutical | Composition for stimulating facial hair growth and methods of manufacturing a composition for stimulating facial hair growth |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5147778B2 (ja) | 1973-12-01 | 1976-12-16 | ||
US4925661A (en) * | 1984-04-19 | 1990-05-15 | Leaf Huang | Target-specific cytotoxic liposomes |
US4957735A (en) * | 1984-06-12 | 1990-09-18 | The University Of Tennessee Research Corporation | Target-sensitive immunoliposomes- preparation and characterization |
US4755388A (en) * | 1984-11-09 | 1988-07-05 | The Regents Of The University Of California | Liposome-encapsulated 5-fluoropyrimidines and methods for their use |
US5223263A (en) * | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
GB8604360D0 (en) * | 1986-02-21 | 1986-03-26 | Univ Dundee | Stimulation of hair growth |
US4806344A (en) | 1987-01-05 | 1989-02-21 | Gaskin Frances C | Sun protectant composition and method |
US4828837A (en) * | 1987-03-30 | 1989-05-09 | Liposome Technology, Inc. | Non-crystalline minoxidil composition, its production and application |
US5290562A (en) * | 1987-11-27 | 1994-03-01 | L V M H Recherche | Compositions and methods employing liposomes including tyrosine or a tyrosine derivative |
FR2628317B1 (fr) * | 1988-03-09 | 1991-11-08 | Lvmh Rech | Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant |
US5077211A (en) * | 1988-07-06 | 1991-12-31 | Applied Genetics, Inc. | Purification and administration of dna repair enzymes |
US5190762A (en) * | 1988-07-06 | 1993-03-02 | Applied Genetics, Inc. | Method of administering proteins to living skin cells |
US5210076A (en) * | 1988-09-13 | 1993-05-11 | Berliner David L | Methods of treating Parkinson's disease using melanin |
IT1231260B (it) * | 1988-11-16 | 1991-11-28 | Sergio Bertini Curri | Farmaco e metodo per aumentare volume e velocita' del flusso microcircolatorio capillare a livello cutaneo |
US5618798A (en) * | 1989-04-20 | 1997-04-08 | Bar-Shalom; Daniel | Use of sucralfate to treat baldness |
FR2648132B1 (fr) * | 1989-06-08 | 1991-09-13 | Thorel Jean | Composes pigmentogenes, leurs vehicules de diffusion, compositions les contenant et leur procede de preparation |
FR2654935B1 (fr) * | 1989-11-28 | 1994-07-01 | Lvmh Rech | Utilisation de xanthines, eventuellement incorporees dans des liposomes, pour favoriser la pigmentation de la peau ou des cheveux. |
GB9014221D0 (en) * | 1990-06-26 | 1990-08-15 | Janssen Pharmaceutica Nv | Method of treating alopecia |
FR2669225B1 (fr) * | 1990-11-21 | 1993-11-12 | Lvmh Recherche Gie | Utilisation de saponines de medicago pour la preparation de compositions cosmetiques ou pharmaceutiques, notamment dermatologiques. |
US5723149A (en) | 1990-11-21 | 1998-03-03 | Lvmh Recherche | Use of medicago saponins for the preparation of cosmetic or pharmaceutical compositions, especially dermatological compositions, promoting renewal of the epidermis, stimulating hair regrowth or delaying hair loss |
DE4113346A1 (de) * | 1991-04-24 | 1992-10-29 | Lang Erich | Zubereitung zur kraeftigung und regeneration des haarwuchses |
WO1993022773A1 (en) * | 1992-05-04 | 1993-11-11 | Berliner David L | Process for absorbing ultraviolet radiation using dispersed melanin |
US5641509A (en) * | 1992-06-26 | 1997-06-24 | Lancaster Group Ag | Preparation for topical use |
FR2694768B1 (fr) * | 1992-07-30 | 1994-12-23 | Pasteur Institut | Séquences d'oligonucléotides pour la détection spécifique de mollicutes par amplication de gènes conservés. |
US5302389A (en) * | 1992-08-17 | 1994-04-12 | Board Of Regents, The University Of Texas System | Method for treating UV-induced suppression of contact hypersensitivity by administration of T4 endonuclease |
CA2159626C (en) * | 1993-04-02 | 2001-10-02 | Lingna Li | Method for delivering beneficial compositions to hair follicles |
-
1994
- 1994-04-01 CA CA002159626A patent/CA2159626C/en not_active Expired - Fee Related
- 1994-04-01 JP JP6522428A patent/JP2950520B2/ja not_active Expired - Lifetime
- 1994-04-01 AU AU65545/94A patent/AU6554594A/en not_active Abandoned
- 1994-04-01 WO PCT/US1994/003634 patent/WO1994022468A1/en active IP Right Grant
- 1994-04-01 AT AT94913349T patent/ATE209887T1/de not_active IP Right Cessation
- 1994-04-01 DE DE69429337T patent/DE69429337T3/de not_active Expired - Lifetime
- 1994-04-01 EP EP94913349A patent/EP0692972B2/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/486,520 patent/US5753263A/en not_active Expired - Lifetime
-
1997
- 1997-05-20 US US08/858,970 patent/US5965157A/en not_active Expired - Lifetime
- 1997-05-20 US US08/858,469 patent/US5914126A/en not_active Expired - Lifetime
- 1997-05-20 US US08/858,929 patent/US6224901B1/en not_active Expired - Lifetime
-
1999
- 1999-05-21 US US09/316,763 patent/US6261596B1/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012157365A (ja) * | 1999-12-10 | 2012-08-23 | Anticancer Inc | 移植用皮膚組織材料 |
JP2009507876A (ja) * | 2005-09-15 | 2009-02-26 | ノヴォソム アクチェンゲゼルシャフト | 両性リポソームにおけるまたはそれに関する改善 |
WO2008053983A1 (fr) * | 2006-11-02 | 2008-05-08 | Hokkaido University | Composition d'ionophorèse pour une administration par les pores des cheveux |
Also Published As
Publication number | Publication date |
---|---|
US5965157A (en) | 1999-10-12 |
EP0692972A4 (en) | 1998-05-06 |
DE69429337T3 (de) | 2012-08-30 |
JP2950520B2 (ja) | 1999-09-20 |
ATE209887T1 (de) | 2001-12-15 |
EP0692972A1 (en) | 1996-01-24 |
CA2159626C (en) | 2001-10-02 |
DE69429337D1 (de) | 2002-01-17 |
US5753263A (en) | 1998-05-19 |
EP0692972B2 (en) | 2012-03-21 |
DE69429337T2 (de) | 2002-10-10 |
WO1994022468A1 (en) | 1994-10-13 |
AU6554594A (en) | 1994-10-24 |
US6224901B1 (en) | 2001-05-01 |
US6261596B1 (en) | 2001-07-17 |
CA2159626A1 (en) | 1994-10-13 |
US5914126A (en) | 1999-06-22 |
EP0692972B1 (en) | 2001-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2950520B2 (ja) | 毛胞に有益な配合物を送達する方法 | |
US5641508A (en) | Method for delivering melanin to hair follicles | |
Hoffman | Topical liposome targeting of dyes, melanins, genes, and proteins selectively to hair follicles | |
US6733776B1 (en) | Method for promoting hair growth | |
AU660767B2 (en) | Method of administering proteins to living skin cells | |
Kay et al. | Imaging synaptic activity in intact brain and slices with FM1-43 in C. elegans, lamprey, and rat | |
EP0879062B1 (en) | Nucleic acid delivery vehicle | |
US7951396B2 (en) | Preparation of nanoliposome-encapsulating proteins and protein-encapsulated nanoliposome | |
US7556825B2 (en) | Method for promoting hair growth | |
CN1217028A (zh) | 调控黑色素合成的方法 | |
Vaccaro et al. | Saposin C induces pH‐dependent destabilization and fusion of phosphatidylserine‐containing vesicles | |
FR2998899A1 (fr) | Methode de criblage a haut-debit pour l'identification de biomarqueurs, cibles therapeutiques ou d'agents therapeutiques | |
Ceccoli et al. | Encapsulation of the UV-DNA repair enzyme T4 endonuclease V in liposomes and delivery to human cells | |
Weiner | Targeted follicular delivery of macromolecules via liposomes | |
EP0935458B1 (fr) | Compositions contenant au moins un acide nucleique | |
US7705126B2 (en) | Compositions for controlling hair growth | |
CN100566810C (zh) | 用脂质膜被覆粒子的方法 | |
EP1723972A1 (fr) | Vectorisation de dsRNA par des particules cationiques et leur utilisation sur modèle de peau. | |
Brus et al. | Distribution and quantification of polyethylenimine oligodeoxynucleotide complexes in human skin after iontophoretic delivery using confocal scanning laser microscopy | |
Simon et al. | Interactions of amphiphilic polyoxazolines formulated or not in lipid nanocapsules with biological systems: Evaluation from membrane models up to in vivo mice epidermis | |
US20070003480A1 (en) | Liposomal composition comprising haptotactic peptides | |
DE60111818T2 (de) | Rekombinanter Vektor zur Gentherapie für Insulin-abhängige Diabetes mellitus und therapeutische Zusammensetzungen davon | |
Lieb | Liposomes and Follicular Penetration | |
Skiba-Lahiani et al. | Interaction between PC12 liposomes encapsulating ATP and human spermatozoa | |
BR102017003860A2 (pt) | composição editora de genoma, processo de obtenção e uso da mesma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070709 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080709 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080709 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090709 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090709 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100709 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110709 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110709 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120709 Year of fee payment: 13 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D03 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130709 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130709 Year of fee payment: 14 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |